Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease
-
Article
Successful treatment of myeloid neoplasms associated with PDGFRA rearrangement with imatinib mesylate
Hypereosinophilic syndromes (HES) constitute a rare and heterogeneous group of disorders, defined as persistent and marked blood eosinophilia associated with evidence of eosinophil-induced organ damage. Cardia...